Postmenopausal Osteoporosis
📧 Sign up to get email alerts when something new happens for Postmenopausal Osteoporosis.
Sign up freeTop drugs studied for this disease
-
EMA approval · 2025-11-27EMA Authorised: Rolcya (denosumab) — Sandoz GmbH
The EMA authorised Rolcya, a denosumab product by Sandoz GmbH, for osteoporosis including postmenopausal osteoporosis.
-
EMA approval · 2025-11-27EMA Authorised: Jubbonti (denosumab) — Sandoz GmbH
EMA authorised Jubbonti, a denosumab product from Sandoz GmbH, for osteoporosis and postmenopausal osteoporosis, reflecting its use in reduc…
-
CLINICAL_TRIALS withdrawal · 2025-11-25Clinical Trial Update: Effect of Mechanical Loading With PTH on Cortical Bone [Phase 4]
Phase 4 trial investigating the effect of mechanical loading with parathyroid hormone on cortical bone in postmenopausal osteoporosis has be…
-
CLINICAL_TRIALS trial_result · 2025-11-24Clinical Trial Update: Efficacy and Safety of Combination Denosumab With Eldecalcitol for Postmenopausal Women With Osteoporosis.(ESCORT) [Phase 4]
Phase 4 study assessing the efficacy and safety of combining denosumab with eldecalcitol for osteoporosis in postmenopausal women.
-
CLINICAL_TRIALS research · 2025-11-21Clinical Trial Update: Bone Turnover Markers and Treatment Efficacy in Postmenopausal Osteoporosis [NA]
This clinical trial is investigating bone turnover markers and treatment efficacy in postmenopausal osteoporosis and is currently recruiting…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-11-03Clinical Trial Update: A Study of Romosozumab (EVENITY®) in Postmenopausal Women in India With Osteoporosis at a High Risk of Fracture. [Phase 4]
Phase 4 study of romosozumab (EVENITY) in postmenopausal women with osteoporosis at high fracture risk in India has completed.
-
FDA approval · 2025-10-29FDA Approved: WYOST — Supplemental Application (Sandoz Inc)
FDA approved a supplemental application for WYOST (denosumab) submitted by Sandoz Inc, expanding the product's indications.
-
FDA approval · 2025-10-29FDA Approved: BILPREVDA — Original Application (Organon LLC)
The FDA approved Bilprevda (denosumab) from Organon LLC under an Original Biologics License Application. The product is approved for postmen…
-
FDA approval · 2025-10-29FDA Approved: ENOBY — Original Application (Hikma Pharmaceuticals USA Inc.)
FDA approved ENOBY (denosumab-qbde) from Hikma Pharmaceuticals USA Inc. via an original biologics license application. ENOBY is a denosumab …
-
EMA approval · 2025-10-22EMA Authorised: Prolia (denosumab) — Amgen Europe B.V.
The EMA authorised Prolia (denosumab) from Amgen Europe B.V. for osteoporosis, including postmenopausal osteoporosis. The decision date was …
-
FDA approval · 2025-10-15FDA Approved: ESTROGENS, CONJUGATED — Original Application (Ingenus Pharmaceuticals, LLC)
FDA approved a generic version of conjugated estrogens under an original ANDA from Ingenus Pharmaceuticals.
-
FDA approval · 2025-10-15FDA Approved: ESTROGENS, CONJUGATED — Original Application (Ingenus Pharmaceuticals, LLC)
FDA approved the original application for a generic conjugated estrogens product from Ingenus Pharmaceuticals, LLC, marking entry of this ge…
-
EMA approval · 2025-10-10EMA Authorised: Teriparatide Sun (teriparatide) — Sun Pharmaceutical Industries Europe B.V.
The EMA authorised Teriparatide Sun for osteoporosis, including postmenopausal osteoporosis.
-
EMA approval · 2025-10-09EMA Authorised: Zadenvi (denosumab) — Zentiva k.s.
EMA authorised Zadenvi (denosumab) for osteoporosis, including postmenopausal osteoporosis, with Zentiva k.s. as the marketing authorisation…
-
CLINICAL_TRIALS research · 2025-10-02Clinical Trial Update: Treatment With Zoledronate Subsequent to Denosumab in Osteoporosis 2 (ZOLARMAB2) [Phase 4]
Phase 4 trial examining zoledronate after denosumab in postmenopausal osteoporosis; the study (ZOLARMAB2) is currently active but not recrui…
-
CLINICAL_TRIALS trial_result · 2025-09-05Clinical Trial Update: Bone Healing After Dental Extraction in Postmenopausal Osteoporotic Women Treated With Alendronate Per os Weekly [NA]
A completed clinical trial update evaluating bone healing after dental extraction in postmenopausal women with osteoporosis treated with wee…
-
CLINICAL_TRIALS trial_result · 2025-08-28Clinical Trial Update: Effect of Muscle Stiffness on Vertebral Fractures in Women Over 60
The study investigates how muscle stiffness may influence vertebral fracture risk in postmenopausal women with osteoporosis; the trial has c…
-
CLINICAL_TRIALS trial_result · 2025-08-24Clinical Trial Update: Efficacy and Safety of Actonel® After Denosumab Discontinuation in Postmenopausal Osteoporosis Women [Phase 4]
A Phase 4 trial evaluates the efficacy and safety of Actonel (risedronate) for patients with postmenopausal osteoporosis after discontinuati…
-
CLINICAL_TRIALS trial_result · 2025-08-19Clinical Trial Update: Comparison of Efficacy, Pharmacodynamics, Safety, and Immunogenicity Between Bmab 1000 and Prolia® in Postmenopausal Women With Osteoporosis [Phase 3]
Phase 3 trial comparing efficacy, pharmacodynamics, safety, and immunogenicity of Bmab 1000 versus Prolia (denosumab) in postmenopausal wome…
-
CLINICAL_TRIALS research · 2025-08-05Clinical Trial Update: Evaluation of Adherence With Bisphosphonates and Calcium and Vitamin D Supplements in Women With Postmenopausal Osteoporosis
A clinical trial is evaluating adherence to bisphosphonate therapy and calcium and vitamin D supplementation in women with postmenopausal os…
-
CLINICAL_TRIALS research · 2025-07-18Clinical Trial Update: Effect of Anti-osteoporotic Medications on Nonalcoholic Fatty Liver Disease [Phase 4]
This is a Phase 4 clinical trial evaluating whether anti-osteoporotic medications affect nonalcoholic fatty liver disease. The study is curr…
-
CLINICAL_TRIALS research · 2025-07-14Clinical Trial Update: A Comparative Study to Valuating the Efficacy and Safety of QL1206 and Prolia® [Phase 3]
Phase 3 trial comparing QL1206 with Prolia (denosumab) in postmenopausal women with osteoporosis at high fracture risk; currently recruiting…
-
CLINICAL_TRIALS research · 2025-07-02Clinical Trial Update: Elucidating the Minimal Effective Dose of Prunes for Bone Health in Postmenopausal Women [NA]
A San Diego State University study is recruiting to determine the minimal effective dose of prunes for improving bone health in postmenopaus…
-
CLINICAL_TRIALS research · 2025-07-01Clinical Trial Update: Evaluation of Osteo-Buddy in Improving Osteoporosis Knowledge [NA]
This clinical trial evaluates the Osteo-Buddy program for improving osteoporosis knowledge, and the study is not yet recruiting.
-
CLINICAL_TRIALS trial_result · 2025-06-25Clinical Trial Update: To Evaluate the Efficacy and Safety of SAL056 for Postmenopausal Women With Osteoporosis at High Fracture Risk [Phase 3]
Phase 3 trial evaluating SAL056 for postmenopausal osteoporosis at high fracture risk has completed; the snippet does not provide efficacy o…